辉瑞溢价收购Array BioPharma，旨在通过后者的Braftovi、Mektovi完善产品线，但是Array对这两款产品的商业化权利只剩下北美了。 6月 ...

2019年07月08日/生物谷BIOON/--Array BioPharma是一家专注于发现、开发和商业化小分子药物治疗癌症的美国生物制药公司。今年6月 ...

Add Yahoo as a preferred source to see more of our stories on Google. NEW YORK (Reuters) - Array BioPharma Inc (ARRY.O) on Thursday sued AstraZeneca AB (AZN.L), accusing the pharmaceutical company of ...

An Array BioPharma investor is facing insider trading allegations, with criminal and civil cases accusing him of unlawfully trading stock options after learning from his wife—an Array employee—that ...

Ambrosia Biosciences has launched with a $16 million series A financing round led by BVF Partners and Boulder Ventures. Ambrosia researchers are developing small-molecule, GLP-1–based drugs for ...

Ever since AstraZeneca licensed the experimental MEK 1/2 inhibitor selumetinib from Array BioPharma in 2003, the drug has been nothing but trouble, failing multiple cancer trials and landing at the ...

Usually, when a biotech company loses a Big Pharma development partner, the executives wind up circling the wagons in a vain attempt to defend the value of their drug ...

CYP2D6 Genotype–Guided Tamoxifen Dosing in Hormone Receptor–Positive Metastatic Breast Cancer (TARGET-1): A Randomized, Open-Label, Phase II Study The ideas and opinions expressed in this Data ...

R.Y. received funding from the National Institutes of Health Cancer Center Support Grant to MSK (P30 CA08748). K.K.C. received funding from the National Institutes of Health Cancer Center Support ...